Assesment of the effects of L-Dopa on Parkinson's Disease
No abstract available.
Saved in:
Main Author: | J. Wright (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
1971-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease
by: Yoshio Goshima, et al.
Published: (2019) -
Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease
by: Sora Ahn, et al.
Published: (2017) -
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA
by: Ting Ting Zhao, et al.
Published: (2017) -
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA
by: Ana Muñoz, et al.
Published: (2020) -
NANOENKAPSULASI L-DOPA DALAM PATI NANOPARTIKEL UNTUK KANDIDAT OBAT ANTI PARKINSON
by: Dhea Salsabila, -
Published: (2022)